FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Interpace Diagnostics ®, a subsidiary of Interpace Biosciences ®, (“Interpace” or the “Company”) (OTCQX: IDXG) today announced notification that the Centers for Medicare & Medicaid Services (CMS) ...

Certain untreated lung cancer patients on England's NHS will ... over the price of the cystic fibrosis drug Orkambi that was only recently resolved through a specialised pricing deal.

Any lingering doubts over the feasibility of rolling out population-based cancer registries in low-income and middle-income ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...